Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of GPX-150 in Patients With Solid Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gem Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00710125
First received: July 2, 2008
Last updated: August 4, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)